Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis, Remittent Progressive”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Post-approval studies (Phase 4)Ended earlyNCT01411514
What this trial is testing

Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Claudio Gobbi 27
Testing effectiveness (Phase 2)Study completedNCT01448252
What this trial is testing

T Cell Vaccination in Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hadassah Medical Organization 30
Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Large-scale testing (Phase 3)Active Not RecruitingNCT06372145
What this trial is testing

Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

Who this might be right for
Relapsing Multiple SclerosisSecondary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
Sanofi 2,500
Early research (Phase 1)Study completedNCT00813969
What this trial is testing

Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS

Who this might be right for
Relapsing-Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
The Cleveland Clinic 24
Large-scale testing (Phase 3)Study completedNCT01917019
What this trial is testing

A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Remittent ProgressiveMultiple Sclerosis, Primary ProgressiveRelapsing-Remitting Multiple Sclerosis+2 more
Biogen 101